Aark Pharmaceuticals Private Limited
Carfilzomib For Injection
Carfilzomib injection available in India. It is used alone to treat relapsed or refractory multiple myeloma. For inquiries about availability, supply, or pricing, patients, doctors, pharmacies, hospitals, B2C pharmacies, and other interested parties are welcome to contact us at at Email: sales@aarkpharma.com or give us a call at M: +91 9999156233 / (+91) 99534-66646.
Generic API Name: Carfilzomib For Injection. Indication: The drug is prescribed for to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with other medications.
Carfilzomib is an anti-cancer medication acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin. Carfilzomib injection is used alone and in combination with other medications to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with other medications.
The FDA approved carfilzomib in July 2012, for use in people with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy (such as lenalidomide) and have demonstrated disease progression on or within 60 days of completion of the last therapy.
CFA, Distributors & Retailers of leading medicine manufacturers in India.
For ordering or sourcing bulk Indian manufactured medicines, contact us @ Mobile/WhatsApp: +91-9999156233 or 011-40743520/21/22/23/24 or you can drop an email to us sales@aarkpharma.co.in, sales@aarkpharma.com
List of Generic Brands for Carfilzomib Injection Available In India from Indian Manufacturers.
Mumbai Office :
9999156233
(Mrs. Himanshi)
Lucknow Office :
7065025552
(Mr. Krishna Kant)
Varanasi Office :
8010447290
(Mr. Dharmendra)
Chandigarh Office :
9876604101
(Mr Bikram)
Kolkata Office :
9810264781
(Mr Surjit)
Patna Office :
9310817125
(Mr. Chitranjan)
Jodhpur Office :
9899245300
(Mr Raju).
Contact
For any inquiries
Yes Carfilzomib Injection is available in following brands as:
Kyfil (Carfilzomib) Injection | Kyprolis (Carfilzomib) Injection | Carzomib (Carfilzomib) Injection | Carfizome (Carfilzomib) Injection | Carfilnat (Carfilzomib) For Injection.
To learn about the cost price or to order Carfilzomib online, please contact:
Seller Name: Aark Pharmaceuticals Private Limited.
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
Mobile / WhatsApp : 9999156233
Email: sales@aarkpharma.co.in, sales@aarkpharma.com
Our Branch Offices in India – New Delhi | Lucknow | Varanasi | Chandigarh | Kolkata | Patna | Jodhpur.
Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price.
Yes individual can order medicines. Aark also serves hospitals, clinics, and registered healthcare professionals
Yes—hospitals and clinics can purchase medicines in bulk through Aark Pharmaceuticals Private Limited, a licensed pharmaceutical wholesaler, or via trusted CFAs, distributors, and retailers of leading medicine manufacturers in India, ensuring safe, compliant, and large-volume procurement.
Aark Pharmaceuticals have delivered Carfilzomib For Injection to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
NEWS / UPDATES
- Dr Reddy’s to market three Amgen drugs in India.
- Amgen gets cosier with Dr. Reddy’s, adding three marketed drugs to Indian partnership.
- Dr. Reddy’s to Market and Distribute Amgen’s RepathaTM (evolocumab), Kyprolis® (carfilzomib) and BLINCYTO® (blinatumomab) in India upon Approval
- Natco Pharma launches generic blood cancer drug in India
- Glenmark to launch blood cancer drug Brukisa in India
- Servier India launch affordable biomarker testing for leukaemia, bile duct cancer.
- Servier gets CDSCO nod for brain cancer drug Voranigo.
- India approves living drug to treat blood cancer: All about Qartemi and how it works.
- Aurobindo Pharma arm gets USFDA nod for generic blood cancer drug.
- GSK’s blood cancer drug gets EU approval
- AstraZeneca gets nod to launch cancer drug




